BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 34508566)

  • 1. Clinical and serological resolution of pembrolizumab associated Sjögren's syndrome: long-term follow-up.
    Clark HJ; Fong PCC; Ng KPL
    Rheumatology (Oxford); 2021 Dec; 61(1):e22-e24. PubMed ID: 34508566
    [No Abstract]   [Full Text] [Related]  

  • 2. A severe case of neuro-Sjögren's syndrome induced by pembrolizumab.
    Ghosn J; Vicino A; Michielin O; Coukos G; Kuntzer T; Obeid M
    J Immunother Cancer; 2018 Oct; 6(1):110. PubMed ID: 30348223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sjögren Syndrome Induced by Immune Checkpoint Inhibitors in a Patient with Advanced Renal Cell Carcinoma.
    Conde-Flores E; Remolina-Bonilla Y; Castro-Alonso F; Martínez-Ibarra N; Hernández-Molina G; Chapa-Ibargüengoitia M; Gamboa-Domínguez A; Bourlon MT
    Oncology (Williston Park); 2021 Aug; 35(8):486-490. PubMed ID: 34398593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sicca syndrome following immune checkpoint inhibition.
    Mavragani CP; Moutsopoulos HM
    Clin Immunol; 2020 Aug; 217():108497. PubMed ID: 32531346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gougerot-Sjogren-like syndrome under PD-1 inhibitor treatment.
    Teyssonneau D; Cousin S; Italiano A
    Ann Oncol; 2017 Dec; 28(12):3108. PubMed ID: 29045656
    [No Abstract]   [Full Text] [Related]  

  • 6. Spectrum and impact of checkpoint inhibitor-induced irAEs.
    Cappelli LC; Bingham CO
    Nat Rev Rheumatol; 2021 Feb; 17(2):69-70. PubMed ID: 33235330
    [No Abstract]   [Full Text] [Related]  

  • 7. Sjögren's syndrome and aromatase inhibitors treatment: is there a link?
    Guidelli GM; Martellucci I; Galeazzi M; Francini G; Fioravanti A
    Clin Exp Rheumatol; 2013; 31(4):653-4. PubMed ID: 23558055
    [No Abstract]   [Full Text] [Related]  

  • 8. Phenytoin-induced pseudo-Sjögren's syndrome.
    Chakravarty K; al-Jafari MS
    Br J Rheumatol; 1996 Oct; 35(10):1033-4. PubMed ID: 8883451
    [No Abstract]   [Full Text] [Related]  

  • 9. Hydrallazine-induced Sjögren's syndrome.
    Darwaza A; Lamey PJ; Connell JM
    Int J Oral Maxillofac Surg; 1988 Apr; 17(2):92-3. PubMed ID: 3133431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sjögren's syndrome precipitated by lamotrigine treatment.
    Chuang JY; Tzeng NS
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Aug; 33(6):1075-6. PubMed ID: 19446598
    [No Abstract]   [Full Text] [Related]  

  • 11. Epirubicin-induced primary Sjögren's syndrome.
    Oxholm A; Frederiksen PL; Oxholm P
    Lancet; 1986 Sep; 2(8507):629-30. PubMed ID: 2875341
    [No Abstract]   [Full Text] [Related]  

  • 12. [Gougerot-Sjögren's syndrome and polyneuritis due to carbimazole (author's transl)].
    Mikol F; Simon F; Falcy M
    Rev Neurol (Paris); 1982; 138(3):259-67. PubMed ID: 7111958
    [No Abstract]   [Full Text] [Related]  

  • 13. Sjögren's Syndrome as an Immune-related Adverse Event of Nivolumab Treatment for Gastric Cancer.
    Higashi T; Miyamoto H; Yoshida R; Furuta Y; Nagaoka K; Naoe H; Naito H; Nakayama H; Tanaka M
    Intern Med; 2020 Oct; 59(20):2499-2504. PubMed ID: 32581160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abducens palsy and Sjogren's syndrome induced by pegylated interferon therapy.
    Oishi A; Miyamoto K; Kashii S; Yoshimura N
    Br J Ophthalmol; 2007 Jun; 91(6):843-4. PubMed ID: 17510485
    [No Abstract]   [Full Text] [Related]  

  • 15. Aspartame-induced Sjögren syndrome.
    Robert HJ
    South Med J; 2006 Jun; 99(6):631-2. PubMed ID: 16800424
    [No Abstract]   [Full Text] [Related]  

  • 16. [Gougerot-Sjögren syndrome induced by D-penicillamine. Apropos of a case].
    May V; Aristoff H; Lecoq G
    Rev Rhum Mal Osteoartic; 1977; 44(7-9):497-501. PubMed ID: 910108
    [No Abstract]   [Full Text] [Related]  

  • 17. Severe cholestasis and sicca syndrome after thiabendazole.
    Bion E; Pariente EA; Maitre F
    J Hepatol; 1995 Dec; 23(6):762-3. PubMed ID: 8750181
    [No Abstract]   [Full Text] [Related]  

  • 18. Development of Sjögren's syndrome during treatment with recombinant human interferon-alpha-2b for chronic hepatitis C.
    Unoki H; Moriyama A; Tabaru A; Masumoto A; Otsuki M
    J Gastroenterol; 1996 Oct; 31(5):723-7. PubMed ID: 8887042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sicca syndrome in a patient with toxic reaction to busulfan.
    Sidi Y; Douer D; Pinkhas J
    JAMA; 1977 Oct; 238(18):1951. PubMed ID: 269293
    [No Abstract]   [Full Text] [Related]  

  • 20. The frequency of sicca syndrome in an elderly female population.
    Strickland RW; Tesar JT; Berne BH; Hobbs BR; Lewis DM; Welton RC
    J Rheumatol; 1987 Aug; 14(4):766-71. PubMed ID: 3668981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.